Prognostic Factors in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials

Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

Richard Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck et al. · European Urology · 2006 · 3K citations

Medicine, Oncology, Urology +10

MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY

Donald L. Lamm, Brent A. Blumenstein, John D. Crissman et al. · The Journal of Urology · 2000 · 1.3K citations

Medicine, Oncology, Urology +11

Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies

Maurizio Brausi, Laurence Collette, Karl‐Heinz Kurth et al. · European Urology · 2002 · 683 citations

Medicine, Surgery, Urology +10

DOES EARLY CYSTECTOMY IMPROVE THE SURVIVAL OF PATIENTS WITH HIGH RISK SUPERFICIAL BLADDER TUMORS?

Harry W. Herr, Pramod C. Sogani · The Journal of Urology · 2001 · 384 citations

Medicine, Surgery, Urology +10

PRIMARY SUPERFICIAL BLADDER CANCER RISK GROUPS ACCORDING TO PROGRESSION, MORTALITY AND RECURRENCE

F. Millán‐Rodríguez, G. Chéchile-Toniolo, J. SALVADOR-BAYARRI et al. · The Journal of Urology · 2000 · 345 citations

Medicine, Oncology, Urology +12